Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The gastroenteritis testing market has witnessed significant expansion in recent years, driven by several key factors. With rising cases of gastrointestinal infections and improvements in diagnostic technologies, this industry is positioned for continued growth. Below, we explore the market size, growth drivers, segments, innovations, key players, and regional outlook shaping this sector.

Gastroenteritis Testing Market Size and Growth Forecast

The gastroenteritis testing market has experienced strong growth historically and is projected to continue on this upward trajectory. From $4.18 billion in 2025, the market is expected to increase to $4.44 billion in 2026, registering a compound annual growth rate (CAGR) of 6.1%. This past growth has largely been driven by reliance on traditional immunoassay and culture-based methods, limited access to advanced molecular diagnostics, rising prevalence of gastrointestinal infections, improved diagnostic capacities in hospitals and clinics, and the expansion of infectious disease research institutions. Looking ahead, the market is forecast to reach $5.55 billion by 2030, growing at a slightly moderated CAGR of 5.8%. This future growth is expected to be fueled by advancements in molecular diagnostic tools, increasing demand for rapid point-of-care testing, more funding for infectious disease research, broader adoption of integrated laboratory information systems, and expansion of testing services in emerging markets. Key trends anticipated during this period include growing emphasis on rapid and precise gastroenteritis diagnostics, increased use of molecular testing methods, broadening of viral, bacterial, and parasitic test panels, expansion of hospital-based and point-of-care diagnostics, and a heightened focus on epidemiological surveillance and outbreak control.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20556&type=smp

Factors Contributing to Gastroenteritis Testing Market Growth

One of the primary drivers behind the gastroenteritis testing market’s expansion is the rising incidence of bacterial infections. This surge is linked to factors such as increased antibiotic resistance, higher population densities, and greater global travel, all of which facilitate the spread of resistant bacterial strains. Accurate gastroenteritis testing plays a critical role in identifying the exact pathogen causing symptoms like diarrhea and vomiting, enabling appropriate treatment and helping to curb further transmission. For example, data from GOV.UK shows that in 2024, cases of bacteraemia caused by antibiotic-resistant bacteria in the UK rose by 9.3%, increasing from 18,740 cases in 2023 to 20,484 cases. This upward trend in bacterial infections is a significant factor propelling demand within the gastroenteritis testing market.

Additional Elements Stimulating Market Demand

Beyond bacterial infection rates, there has been a growing need for faster, more accurate diagnostic solutions to manage gastroenteritis outbreaks effectively. Enhanced awareness about infection control, greater investments in healthcare infrastructure, and technological innovations contribute to the broader adoption of advanced testing methods. These elements collectively support the ongoing expansion of the gastroenteritis testing industry worldwide.

Access The Complete Gastroenteritis Testing Market Report:

https://www.thebusinessresearchcompany.com/report/gastroenteritis-testing-global-market-report

An Overview of Gastroenteritis Testing Market Segmentation

The gastroenteritis testing market encompasses several important segments, structured by type, disease strains, testing methods, and end-users. By type, the market includes viral gastrointestinal infections, bacterial gastrointestinal infections, and parasitic gastrointestinal infections. Disease strains are categorized as bacterial strains, viral strains, and parasitic strains. Testing approaches comprise immunoassay testing, conventional methods, and molecular diagnostic testing. End-use segments cover hospitals, clinics or medical centers, research institutes, and diagnostic laboratories. Further breakdown reveals specific viral infections such as Norovirus, Rotavirus, Astrovirus, Adenovirus, and Sapovirus; bacterial infections including Escherichia coli (E. coli), Salmonella, Campylobacter, Shigella, and Clostridium perfringens; and parasitic infections like Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella, and Strongyloides stercoralis. These subdivisions highlight the broad scope and complexity of the gastroenteritis testing market.

Innovations Driving Transformation in Gastroenteritis Testing

Leading companies in the gastroenteritis testing space are focusing on developing highly sensitive and specific molecular diagnostic products. Molecular gastrointestinal tests, which utilize techniques such as polymerase chain reaction (PCR), have become essential diagnostic tools as they detect and identify genetic material from pathogens in gastrointestinal samples quickly and accurately. A notable example occurred in June 2024, when Germany-based QIAGEN N.V. introduced the QIAstat-Dx Gastrointestinal Panel 2. This innovative panel can rapidly and comprehensively identify up to 16 clinically significant bacterial, viral, and parasitic pathogens responsible for the majority of gastrointestinal infections. Using real-time PCR technology, it amplifies multiple genetic targets simultaneously in a single test, providing results much faster than traditional culture-based microbiological methods, which often require anywhere from 24 hours to 10 days.

Key Players and Competitive Landscape of the Gastroenteritis Testing Market

The gastroenteritis testing market features a range of prominent companies contributing to its growth and innovation. Top participants include F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott Diagnostics, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Hologic Inc., Becton Dickinson and Company, bioMérieux SA, Quest Diagnostics Incorporated, DiaSorin S.p.A., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., ARUP Laboratories, Meridian Bioscience Inc., MedGenome, Trinity Biotech plc, Savyon Diagnostics Ltd., Coris BioConcept, Aster Clinical Research & Diagnostic Centre Pvt. Ltd., Alimetrix Inc., and Luminex Corporation. These organizations drive research, develop innovative diagnostics, and help expand testing accessibility globally.

Regional Trends and Market Leadership in Gastroenteritis Testing

In 2025, North America held the largest share of the gastroenteritis testing market, reflecting the region’s advanced healthcare infrastructure and high adoption of diagnostic technologies. Meanwhile, the Asia-Pacific region is expected to experience the fastest market growth over the coming years, driven by improving healthcare systems, increasing investments, and rising awareness about gastrointestinal diseases. The geographic breakdown of this market includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model